Home
>
National Drug Code (NDC)
>
Intelence
Intelence - 59676-571-01 - (etravirine)
Drug Information of Intelence
| Product NDC: | 59676-571 |
| Proprietary Name: | Intelence |
| Non Proprietary Name: | etravirine |
| Active Ingredient(s): | 200 mg/1 & nbsp; etravirine |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of Intelence
| Product NDC: | 59676-571 |
| Labeler Name: | Janssen Products LP |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA022187 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20101222 |
Package Information of Intelence
| Package NDC: | 59676-571-01 |
| Package Description: | 60 TABLET in 1 BOTTLE, PLASTIC (59676-571-01) |
NDC Information of Intelence
| NDC Code | 59676-571-01 |
| Proprietary Name | Intelence |
| Package Description | 60 TABLET in 1 BOTTLE, PLASTIC (59676-571-01) |
| Product NDC | 59676-571 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | etravirine |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 20101222 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Products LP |
| Substance Name | ETRAVIRINE |
| Strength Number | 200 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Human Immunodeficiency Virus 1 Non-Nucleoside Analog Reverse Transcriptase Inhibitor [EPC],Non-Nucleoside Analog [Chemical/Ingredient],Non-Nucleoside Reverse Transcriptase Inhibitors [MoA] |
